A Philadelphia jury found Tuesday that GlaxoSmithKline failed to properly warn doctors and pregnant women about risks associated with its blockbuster antidepressant Paxil. The jury awarded $2.5 million in damages to the family of Lyam Kilker, who was born with heart defects after his mother took Paxil during her pregnancy. As the first trial of more than 600 suits claiming Glaxo hid knowledge of birth defect risks allegedly tied to Paxil, the case was closely watched as a test of Glaxo's vulnerability.
Glaxo Hit With $2.5 Million Jury Verdict in Paxil Test Case
The American Lawyer
October 14, 2009